Symphony Asset Management’s Teladoc Health TDOC Stock Holding History

Symphony Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1.93M	Buy	+10,100	New	+$1.77M	0.62%	33
2020 Q1	–	Sell	-37,424	Closed	-$3.13M	–	144
2019 Q4	$3.13M	Buy	37,424 +15,624	+72%	+$1.19M	0.69%	22
2019 Q3	$1.48M	Buy	+21,800	New	+$1.43M	0.32%	37
2019 Q2	–	Sell	-4,744	Closed	-$264K	–	200
2019 Q1	$264K	Buy	+4,744	New	+$290K	0.07%	135

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Symphony Asset Management's TDOC Position: Q2 2020 in Review

Symphony Asset Management opened a new position in Teladoc Health (TDOC) in Q2 2020: 10,100 shares worth $1.93M. The stake represents 0.62% of the portfolio and ranks #33 among its holdings. This is a return to the name: Symphony Asset Management previously reported a position in TDOC as recently as Q4 2019.

Symphony Asset Management first reported a position in TDOC in Q1 2019 and has held it in 4 quarters since. The position peaked at $3.13M in Q4 2019. 669 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Symphony Asset Management held 10,100 shares of Teladoc Health worth $1.93M as of Q2 2020.
Teladoc Health was a new Symphony Asset Management position in Q2 2020.
Teladoc Health made up 0.62% of Symphony Asset Management's portfolio in Q2 2020, its #33 holding.
Symphony Asset Management first reported a position in Teladoc Health in Q1 2019 and has held it in 4 quarters since.
Symphony Asset Management's Teladoc Health position peaked at $3.13M in Q4 2019.
669 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Symphony Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.